advaxis-squarelogo-1498831554460.png
Advaxis to Present at the Non-Small Cell Lung Cancer Drug Development Summit
July 14, 2021 16:01 ET | Advaxis, Inc.
PRINCETON, N.J., July 14, 2021 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products,...
logo1
Galapagos demonstrates early clinical activity with SIK2/3 inhibition in inflammation
July 14, 2021 16:01 ET | Galapagos NV
Biologic effect of salt inducible kinase (SIK) mechanism in first patient studies supports further progression of Toledo portfolioSIK2/3 inhibitor GLPG3970 generally safe and well-toleratedStudy in...
logo1
Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study
July 14, 2021 16:01 ET | Galapagos NV
Generally safe and well toleratedPositive efficacy signal in psoriasis patients at Week 440% of patients showed improvement of at least 50% in PASI response (PASI 50) with high dose of GLPG3667 at...
QCILogo (1).png
Quantum Computing Inc. Lists on Nasdaq Capital Market
July 14, 2021 16:01 ET | Quantum Computing Inc.
LEESBURG, Va., July 14, 2021 (GLOBE NEWSWIRE) -- Quantum Computing Inc. (the “company” or “QCI”) (OTCQB: QUBT) (Nasdaq: QUBT), a leader in bridging the power of classical and quantum computing, has...
evelo-logo.png
Evelo Biosciences Announces Grant of Inducement Award
July 14, 2021 16:01 ET | Evelo Biosciences, Inc.
CAMBRIDGE, Mass., July 14, 2021 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, announced...
NexImmune Logo.jpg
NexImmune Strengthens Management Team with Key Appointments
July 14, 2021 16:01 ET | NexImmune, Inc.
Dr. Jack A. Ragheb as Senior Vice President, Translational ScienceMatt Schiller, Head of Business Development GAITHERSBURG, Md., July 14, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a...
zogenixlogo.png
VIP Siblings and www.vipsibling.com, New Resources to Support Brothers & Sisters of Those Living with Severe, Rare Epilepsies, Now Available from Zogenix and 10 Advocacy Groups
July 14, 2021 16:01 ET | Zogenix, Inc
EMERYVILLE, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Zogenix, a global biopharmaceutical company developing rare disease therapies, and ten U.S. advocacy groups today announced the launch of VIP...
Colliers.jpg
Colliers International Group Inc. to Announce Second Quarter Results on August 4, 2021
July 14, 2021 16:00 ET | Colliers International Group Inc.
TORONTO, July 14, 2021 (GLOBE NEWSWIRE) -- Colliers International Group Inc. (TSX: CIGI; NASDAQ: CIGI) (“Colliers” or the “Company”) announced today that results for the second quarter ended June...
Sotherly Hotels Inc. logo
Sotherly Hotels Inc. Schedules Second Quarter 2021 Earnings Release and Conference Call
July 14, 2021 16:00 ET | Sotherly Hotels Inc.
WILLIAMSBURG, Va., July 14, 2021 (GLOBE NEWSWIRE) -- Sotherly Hotels Inc. (NASDAQ: SOHO) (the “Company”) announced that the Company will report financial results for the second quarter 2021 prior to...
freehold.png
Freehold Royalties Ltd. Declares Dividend for July 2021
July 14, 2021 16:00 ET | Freehold Royalties Ltd.
CALGARY, Alberta, July 14, 2021 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX: FRU) announces that its Board of Directors has declared a dividend of Cdn. $0.04 per common share to be...